Bristol Myers Squibb Company

Associate Research Scientist

Cambridge, MA, US
Nov 13, 2018
Required Education
Bachelors Degree
Position Type
Full time
Associate Research Scientist (Immunology-focus - Immuno-Oncology)

Bristol-Myers Squibb R&D is a science-driven, passionate organization determined to discover, develop and deliver medicines that have the potential to transform the lives of patients and establish new standards of care in areas of high unmet need. Patients' needs and scientific discovery are our driving force. The new Bristol-Myers Squibb research site in Cambridge's Kendall Square will position our scientific team in the heart of a vibrant ecosystem of world-class science, innovation and business opportunities. Our scientists will focus on novel targets and pathways for tumors that are refractory to current Immuno-Oncology therapies. These are significant challenges that will require innovative solutions from the biopharma, biotech and academic communities.

Roles and Responsibilities

We are seeking a Research Scientist, who has experience in basic molecular and cellular techniques, including handling clinical specimens, isolation of RNA/DNA/Protein, gene expression analysis, ELISA, in vitro cell culturing and pre-clinical cell-based assays in a translational setting to join our team.

Qualifications / Essential Skills
  • BS with 1-2yr or MS in Immunology, cell biology or a related field
  • Beneficial if candidate will have experience in any aspect of in vitro or in vivo characterization of cancer models, although could be wholly trained in-house.
  • Prior knowledge of current immune checkpoint therapeutic landscape would be an advantage but any experience as it relates to resistance mechanisms would be desirable
  • Excellent written and oral presentation skills
  • A self-starter, who is /can become technically proficient in a diverse set of techniques and assays that complement the immune-oncology program
  • Early career position for a highly motivated individual

We follow the science and we'll continue to invest in translational medicine research, deepen our understanding of disease biology and uncover insights about predictive biomarkers with the ultimate goal of making precision medicine a reality for more patients.